Key facts
- Notable investors include Zhongyiren Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vitol Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Vitol Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vitol Biotechnology
Developer of biotechnology products focused on the research and development of biomedical and life science technologies. The company develops biological reagents, diagnostic tools, laboratory technologies, research materials and technical services that serve healthcare institutions and research laboratories and enable scientific research and clinical analysis.
- Sector
- Healthcare
- HQ
- Huzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Vitol Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vitol Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vitol Biotechnology in its N-PORT filings yet. We sweep new filings monthly.